Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2003
05/22/2003WO2003041493A1 Production of recombinant antibodies by means of fusion with elastin-like peptides
05/22/2003WO2003012089A3 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
05/22/2003WO2003003904A3 Coactivators in the diagnosis and treatment of breast cancer
05/22/2003WO2002102987A3 Methods and compositions based on protein interactions with mastermind
05/22/2003WO2002102974A3 Mutant proteins, high potency inhibitory antibodies and fimch crystal structure
05/22/2003WO2002092770A3 Novel method for cloning variable domain sequences of immunological gene repertoire
05/22/2003WO2002078766A3 Combination therapy
05/22/2003WO2002056831A3 Immunogenic proteoliposomes, and uses thereof
05/22/2003WO2002053740A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/22/2003WO2002050283A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/22/2003WO2002044215A3 Hybrid antibodies
05/22/2003WO2002023202A3 Method to identify antibody targets based on mass spectrometry (maldi-tof)
05/22/2003WO2002022807A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof
05/22/2003WO2001068708A9 Human and humanized fap-alpha-specific antibodies
05/22/2003US20030097667 For therapy of Alzheimers disease, diagnosis
05/22/2003US20030096982 Nucleotide sequences coding polypeptide for use in the treatment of immunological, reproductive and liver disorders
05/22/2003US20030096977 Antibody against human interleukin-5 receptor alpha chain
05/22/2003US20030096976 Humanized antibodies LB-00503 and LB-00506 specific for human 4-1BB and pharmaceutical compositions comprising said humanized antibodies
05/22/2003US20030096975 Peptide for use in the prevention and treatment of microorganismal infections
05/22/2003US20030096958 Polypeptide for use in the treatment of cancer and kidney disorders
05/22/2003US20030096955 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096954 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096947 Placental organic anion transporter and gene thereof
05/22/2003US20030096823 Method for the treatment of cardiotoxicity induced by antitumor compounds
05/22/2003US20030096790 Bacterial antigens for an immunological test for infection of by a Grampositive bacterium; diagnosing infection associated with central venous catheters, prosthetic devices, and cerebrospinal fluid shunts
05/22/2003US20030096781 Interleukin-8 (IL-8); antisense nucleotide targeted to IL-8 for rapid treatment without the associated cumulative toxicity of conventional treatments
05/22/2003US20030096779 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies
05/22/2003US20030096765 Aromatic esters; cytotoxic agents; antitumor agents
05/22/2003US20030096756 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096755 Suppression of inhibitors
05/22/2003US20030096749 Human cytokine receptor
05/22/2003US20030096746 Compounds and methods for inhibiting cancer metastasis
05/22/2003US20030096744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096742 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096403 Humanized antibody to surface antigen s of hepatitis b virus and a preparing method thereof
05/22/2003US20030096402 Chemically defined medium for cultured mammalian cells
05/22/2003US20030096386 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder
05/22/2003US20030096373 Antibody for use in the detection of tumors
05/22/2003US20030096369 Non-anaphylactogenic IgE vaccines
05/22/2003US20030096368 Nucleotide sequences coding bactericide for use in the treatment and prevention of neisseria infections
05/22/2003US20030096363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096357 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096350 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096343 Modular assembly of antibody genes, antibodies prepared thereby and use
05/22/2003US20030096340 Nucleotide sequences coding polypeptide for use in the treatment, diagnosi and prevention of skin, kidney and cell proliferative disorders
05/22/2003US20030096327 Detection of tumor disorder in humans; obtain tissue sample, screen for presence of tumor marker, presence of marker indicates tumor disorder
05/22/2003US20030096320 Oil bodies and associated proteins as affinity matrices
05/22/2003US20030096317 Detection of graves' disease or rheumatoid arthritis in humans; obtain sample, incubate with immunoglobulins, detect signal, measure signal compare to control, amplified signal indicates graves or arthritic disorders
05/22/2003US20030096313 Novel serine-threonine kinase-4
05/22/2003US20030096312 Novel natrium-calcium exchanger protein
05/22/2003US20030096308 Peptide sequence tags and method of using same
05/22/2003US20030096306 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
05/22/2003US20030096304 Nuclear matrix protein fluid assay
05/22/2003US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof
05/22/2003US20030096285 Detection of targets for anticarcinogenic agents; obtain tumor cells, determine protein expression pattern, compare to wild type, isolate differentially expessed proteins, use protein as diagnostic tool
05/22/2003US20030096282 Gtpase-activating protein 1
05/22/2003US20030096267 Essential bacterial genes and their use
05/22/2003US20030096250 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infection of mammals
05/22/2003US20030096247 Human cDNAs and proteins and uses thereof
05/22/2003US20030096237 Determination of the ability of patients to respond to a tumor treatment
05/22/2003US20030096233 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096226 Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitope
05/22/2003US20030096225 Recovering preferential protein from library; obtain cell, transform with vector, express vector, isolate preferential protein
05/22/2003US20030096022 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
05/22/2003US20030095985 Immunogenic conjugates of Gram-negative bacterial autoinducer molecules and antibodies raised against the same
05/22/2003US20030095977 Use of fusion proteins, especially scFvSA, as diagnostic markers or as cell specific targeting agents.
05/22/2003US20030095976 Methods to improve immunogenicity of antigens and specificity of antibodies
05/22/2003US20030095973 Chlamydia antigens and corresponding DNA fragments and uses thereof
05/22/2003US20030095972 Administration of phosphorylated Mammastatin having a molecular weight of 53 kDa or 49 kDa; the polypeptide is specifically reactive with monoclonal antibody 7G6 that is produced from hybridoma ATCC No. HB10152
05/22/2003US20030095969 Administering an anti-VLA-4 antibody, a monoclonal antibody recognizing VLA-4, or a soluble VCAM-1 polypeptide.
05/22/2003US20030095967 BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
05/22/2003US20030095966 Method of blocking tissue destruction by autoreactive T cells
05/22/2003US20030095965 Antibodies to Ly49E and CD94/NKG2 receptors
05/22/2003US20030095964 Process for producing humanized chimera antibody
05/22/2003US20030095963 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma
05/22/2003US20030095962 Chimeric cell-surface receptors that undergo antigen-induced association
05/22/2003US20030095960 Three human transferases, polynucleotides that identify and encode them, expression vectors, host cells, antibodies, agonists, and antagonists.
05/22/2003US20030095890 Irradiating the material, especially combined with a stabilizer for protection from the radiation
05/22/2003CA2505342A1 Bispecific antibody molecule
05/22/2003CA2467433A1 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
05/22/2003CA2467424A1 Treatment of inflammatory conditions
05/22/2003CA2467347A1 Histamine receptor h3 polynucleotides
05/22/2003CA2467229A1 Dexrazoxane for treating antitumor-induced cardiotoxicity
05/22/2003CA2467052A1 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
05/22/2003CA2467032A1 Method to obtain protection against bystander allergen
05/22/2003CA2466769A1 Methods of expressing lim mineralization protein in non-osseous cells
05/22/2003CA2466641A1 Lyophilized monoclonal antibody compositions
05/22/2003CA2466592A1 Modified anti-tnf alpha antibody
05/22/2003CA2466521A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003CA2466420A1 A novel saitohin gene and uses of same
05/22/2003CA2466415A1 Pgc-1.beta., a novel pgc-1 homologue and uses therefor
05/22/2003CA2466346A1 Single nucleotide polymorphisms in gh-1
05/22/2003CA2466279A1 Agents that modulate immune cell activation and methods of use thereof
05/22/2003CA2466118A1 Modulation of lir function to treat rheumatoid arthritis
05/22/2003CA2463639A1 Growth hormone variations in humans and their uses
05/22/2003CA2460959A1 Enzymes
05/22/2003CA2454031A1 Novel chromophores/fluorophores and methods for using the same
05/21/2003EP1312378A1 Agents for ameliorating symptoms caused by joint diseases
1 ... 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 ... 1494